A cohort-aware reanalysis of four public single-cell RNA sequencing datasets has revealed that a prominent type I interferon program is specific to primary Sjögren’s syndrome rather than shared with periodontitis. Researchers reevaluated the hypothesized peripheral immune dysregulation linking the two conditions, addressing previous published comparisons that relied on bulk transcriptomes or analytical tests that treated individual cells as independent replicates. By establishing the individual donor as the unit of inference and comparing cases strictly against controls from the same cohort, the investigation tested whether previously reported immune parallels withstand rigorous donor-level evaluation.
The study analyzed peripheral blood mononuclear cell profiles across two periodontitis cohorts and two primary Sjögren’s syndrome cohorts. Following the removal of eight duplicated samples, the final curated dataset included 48 donors—comprising 24 controls, 10 periodontitis patients, and 14 primary Sjögren’s syndrome patients—and 317,205 cells grouped into 28 subsets. The researchers evaluated three distinct layers of data: cell-type composition, pseudobulk gene expression, and consensus regulon activity. A finding was classified as replicated only if it achieved statistical significance with a false discovery rate below 0.05 in a pooled model and reached significance in both individual cohorts of a disease.
When evaluated against this replication standard, periodontitis demonstrated no replicated alterations across any analytical layer, and its transcriptome-wide perturbation did not exceed the permutation null. In contrast, primary Sjögren’s syndrome exhibited a robust type I interferon program spanning multiple cell lineages. Specific transcription factor regulons, including STAT1(+), STAT2(+), ETV7(+), and IRF7(+), accounted for 25 of the 44 replicated regulon–subset pairs identified in the syndrome. The target genes of these regulons were interferon-stimulated genes, which represented the dominant component of replicated differentially expressed genes.
The identified interferon signature reliably distinguished primary Sjögren’s syndrome from periodontitis, yielding an area under the receiver operating characteristic curve between 0.90 and 0.95. Furthermore, this interferon signal was driven primarily by intracellular transcriptional changes rather than shifts in cell abundance; in the larger primary Sjögren’s syndrome cohort, 93 percent of the peripheral blood mononuclear cell interferon signal arose from elevated expression within cells. In addition to the interferon program, both cohorts of primary Sjögren’s syndrome displayed a consistent reduction in naive and central memory CD4-positive T cells.
Direct cross-disease concordance between periodontitis and primary Sjögren’s syndrome was weak, though it exceeded permutation nulls for both regulons (Spearman’s rho = 0.38, P = 0.031) and gene expression (rho = 0.13, P = 0.012). This limited convergence consisted of two distinct features: a compositional shift within natural killer cells marked by fewer CD56dim natural killer cells and an increased frequency of a mixed T-like or adaptive-like natural killer subset across all four cohorts, alongside lower expression of glucocorticoid- and stress-responsive genes across lineages in cases.
The findings also highlighted significant methodological confounding when study cohorts are improperly combined. When controls across studies were pooled rather than compared within their respective cohorts, the data produced apparent shared regulons that failed to survive cohort-aware testing. Between 39 percent and 68 percent of regulon–subset pairs differed significantly between the healthy controls of the periodontitis and primary Sjögren’s syndrome studies. Replicated peripheral immune changes were therefore concluded to be specific to primary Sjögren’s syndrome, while shared peripheral features between the two diseases are confined to a natural killer subset shift and a stress-response signature of uncertain origin.
Subject of Research: Single-cell transcriptomic evaluation of peripheral immune dysregulation in periodontitis and primary Sjögren’s syndrome
Article Title: Cohort-aware single-cell analysis of PBMCs identifies an interferon program specific to primary Sjögren’s syndrome and limited immune convergence with periodontitis
Article References: Qin, T., Sun, C., Sun, J., Zhang, A., Zhang, X., Chen, L., & Zhou, Q. (2026). Cohort-aware single-cell analysis of PBMCs identifies an interferon program specific to primary Sjögren’s syndrome and limited immune convergence with periodontitis. Frontiers in Cell and Developmental Biology, 14, Article 1969882. https://doi.org/10.3389/fcell.2026.1969882
Image Credits: AI Generated
DOI: 10.3389/fcell.2026.1969882
Keywords: primary Sjögren's syndrome, periodontitis, single-cell RNA sequencing, peripheral blood mononuclear cells, type I interferon, donor-level inference, pseudobulk expression, regulon activity, STAT1, STAT2, ETV7, IRF7, interferon-stimulated genes, CD56dim NK cells, adaptive-like NK cells, CD4+ T cells, glucocorticoid-responsive genes, batch confounding
News Source: Juliet Wilcox. (November 14, 2026). Cohort-Aware Analysis Finds Interferon Program Is Specific to Sjögren’s Syndrome. Scienmag.



